Nasopharyngeal competition dynamics are likely to be altered following vaccine introduction: bacteriocin prevalence and diversity among Icelandic and Kenyan pneumococci

Autor: Madeleine EB Butler, Melissa J Jansen van Rensburg, Angela Karani, Benedict Mvera, Donald Akech, Asma Akter, Calum Forrest, Andries J van Tonder, Sigríður J Quirk, Gunnsteinn Haraldsson, Stephen D Bentley, Helga Erlendsdóttir, Ásgeir Haraldsson, Karl G Kristinsson, J Anthony G Scott, Angela B Brueggemann

Bacteriocins are antimicrobial peptides produced by bacteria to inhibit other bacteria in the surrounding environment.Streptococcus pneumoniaeis a leading cause of disease worldwide and colonises the healthy human nasopharynx, where it competes for s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07132374796e547ed454050fa014aa61
https://doi.org/10.1101/2022.11.03.514821

Personalized Brachytherapy: Applications and Future Directions.

Autor: Pathak P; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX 77030, USA., Thomas JJ; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX 77030, USA., Baghwala A; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Li C; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Farach AM; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Oct 09; Vol. 16 (19). Date of Electronic Publication: 2024 Oct 09.

An Insight into Perfusion Anisotropy within Solid Murine Lung Cancer Tumors.

Autor: Martino A; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.; Department of Materials Science and Engineering, University of Houston, Houston, TX 77024, USA., Terracciano R; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.; Department of Electronics and Telecommunications, Politecnico di Torino, 10129 Torino, Italy., Milićević B; Bioengineering Research and Development Center (BioIRC), 34000 Kragujevac, Serbia.; Faculty of Engineering, University of Kragujevac, 34000 Kragujevac, Serbia., Milošević M; Bioengineering Research and Development Center (BioIRC), 34000 Kragujevac, Serbia.; Institute for Information Technologies, University of Kragujevac, 34000 Kragujevac, Serbia.; Faculty of Information Technology, Belgrade Metropolitan University, 11000 Belgrade, Serbia., Simić V; Bioengineering Research and Development Center (BioIRC), 34000 Kragujevac, Serbia.; Institute for Information Technologies, University of Kragujevac, 34000 Kragujevac, Serbia., Fallon BC; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Carcamo-Bahena Y; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Royal ALR; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Carcamo-Bahena AA; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Butler EB; Department of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030, USA., Willson RC; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77024, USA., Kojić M; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.; Bioengineering Research and Development Center (BioIRC), 34000 Kragujevac, Serbia.; Serbian Academy of Sciences and Arts, 11000 Belgrade, Serbia., Filgueira CS; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.; Department of Cardiovascular Surgery, Houston Methodist Research Institute, Houston, TX 77030, USA.

Publikováno v: Pharmaceutics [Pharmaceutics] 2024 Jul 30; Vol. 16 (8). Date of Electronic Publication: 2024 Jul 30.

Personalized Radiation Therapy for Breast Cancer.

Autor: Haque W; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 20; Vol. 31 (3), pp. 1588-1599. Date of Electronic Publication: 2024 Mar 20.

Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 Inhibitor.

Autor: Hunt A; Department of Radiation Oncology, University of Texas Medical Branch, Galveston, TX, U.S.A., Haque W; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Pino R; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Farach A; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A. bteh@houstonmethodist.org.

Publikováno v: Anticancer research [Anticancer Res] 2023 Aug; Vol. 43 (8), pp. 3539-3542.